Alice Blue Home
URL copied to clipboard

Trending News

Pharma stock jumps 10% after CDMO receives approval to list its equity shares for trading on BSE and NSE

Pharma stock's subsidiary received NSE and BSE listing approval, with trading starting January 24, 2025, enhancing market visibility and positioning it as a key player in India’s specialty pharmaceutical sector.
Pharma stock jumps 10% after CDMO receives approval to list its equity shares for trading on BSE and NSE
Pharma stock jumps 10% after CDMO receives approval to list its equity shares for trading on BSE and NSE

Introduction:

A leading pharma stock announced its subsidiary’s equity listing approval on NSE and BSE. Trading starts January 24, 2025, enhancing market visibility and positioning it as a key player in India’s specialty pharmaceutical sector, boosting investor confidence.

Alice Blue Image

Share Price movement of  Strides Pharma Science:

On January 23, 2025, Strides Pharma Science Ltd opened at ₹583.30 and surged 10% to ₹637.35 by 02:19 PM. The stock hit an intraday high of ₹637.95 and low of ₹583.30, with a market cap of ₹5,809.48 crore.

Strides Pharma Science share price rise:

Strides Pharma Science Limited announced that its subsidiary, OneSource Specialty Pharma Limited, India’s first Specialty Pharma CDMO, received listing and trading approval for its equity shares from NSE and BSE on January 22, 2025. Trading begins on January 24, 2025.

OneSource will trade under the codes ONESOURCE (NSE) and 544292 (BSE), marking a significant milestone in its journey. This listing enhances its market visibility and positions it as a key player in the specialty pharmaceutical sector.

The development reflects OneSource’s growth potential and industry significance, as highlighted by Strides Pharma Science Limited. Stakeholders anticipate the trading debut, strengthening confidence in the company’s prospects in the pharmaceutical market.

Also Read: Stocks To Watch For Budget 2025

Recent news About Strides Pharma Science :

On December 11, 2024, OneSource allotted equity shares to Strides Pharma shareholders per a 1:2 ratio. Shares will be credited to demat accounts, with fractional entitlements consolidated, sold within 90 days, and proceeds distributed to eligible shareholders.

Ace investor holding of Strides Pharma Science:

Ace investor Mukul Mahavir Agrawal holds 10,66,000 shares of Strides Pharma Science Ltd, valued at ₹67.3 crore. This represents a 36% reduction in his holdings compared to the previous quarter, reflecting strategic adjustments in his portfolio.

Stock performance of Strides Pharma Science for Period of 1 week, 6 months and 1 year:

Strides Pharma Science stock declined by 7.05% over the past week but gained 21.4% in the last six months. Over the past year, the stock delivered a remarkable return of 84.6%, showcasing strong performance across longer timeframes.

Also Read: Best Sectors To Watch For Budget 2025

Shareholding pattern of Strides Pharma Science:

All values in %Dec-24Sep-24Jun-24
Promoters26.8225.8425.86
FII28.4830.0826.71
DII16.9218.2418.55
Retail & others27.7925.8428.88
Alice Blue Image

About Strides Pharma Science:

Strides Pharma Science Ltd is a global pharmaceutical company specializing in the development, manufacturing, and distribution of generic drugs. It focuses on regulated markets, niche segments, and innovative formulations, contributing significantly to the healthcare sector worldwide.
Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.

Loading
Submit the form, and get to know how you scored!!!
Submit the form, and get to know how you scored!!!
Read More News
डिफेंस स्टॉक में 3% तेजी, ड्रोन, UAVs और अन्य रक्षा उत्पादों के विस्तार के लिए 12,700 करोड़ रुपये के समझौतों के बाद ।

डिफेंस स्टॉक में 3% तेजी, ड्रोन, UAVs और अन्य रक्षा उत्पादों के विस्तार के लिए 12,700 करोड़ रुपये के समझौतों के बाद ।

डिफेंस स्टॉक की सहायक इकाई ने महाराष्ट्र सरकार के साथ नागपुर में 12,700 करोड़ रुपये की एक बड़ी रक्षा परियोजना

Open Demat Account With

Account Opening Fees!

Enjoy New & Improved Technology With
ANT Trading App!